Home > Back to Publisher > Report Information

OTC Healthcare in North America to 2011

Datamonitor
August 11, 2008
89 Pages - SKU: DFMN1872820

Abstract Table of Contents Search inside this report Related Reports

Countries covered: North America

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in North America. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011 for 02 countries covered within the North America region.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume data by market, segment and sub segment

Highlights

The North America OTC Healthcare market covering 02 countries, increased between 2001-2006, growing at an average annual rate of 3.2%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Wyeth is third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns for the 02 countries covered
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 2 OVERVIEW
: Value Analysis
Chapter 3 NORTH AMERICA OTC HEALTHCARE - MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc; GlaxoSmithKline
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Company Share Analysis
Chapter 15 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 16 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: North America OTC Healthcare value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 2: North America OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: North America OTC Healthcare company share (Top 5 companies), by value, 2005-2006 (%); Figure 4: North America Analgesics value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 5: North America Analgesics category growth comparison, by value, 2001-2011; Figure 6: North America Analgesics company share (Top 5 companies), by value, 2005-2006 (%); Figure 7: North America Cough and Cold Preparations value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 8: North America Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: North America Cough and Cold Preparations company share (Top 5 companies), by value, 2005-2006 (%); Figure 10: North America Traditional Medicines value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 11: North America Traditional Medicines company share, by value, 2005-2006 (%); Figure 12: North America First Aid Kits value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 13: North America First Aid Kits company share (Top 5 companies), by value, 2005-2006 (%); Figure 14: North America Indigestion Preparations value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 15: North America Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 16: North America Indigestion Preparations company share (Top 5 companies), by value, 2005-2006 (%); Figure 17: North America Vitamins and Minerals value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 18: North America Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 19: North America Vitamins and Minerals company share (Top 5 companies), by value, 2005-2006 (%); Figure 20: North America Plasters & Bandages value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 21: North America Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 22: North America Plasters & Bandages company share (Top 5 companies), by value, 2005-2006 (%); Figure 23: North America Medicated Skin Products value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 24: North America Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 25: North America Medicated Skin Products company share (Top 5 companies), by value, 2005-2006 (%); Figure 26: North America Other OTC Healthcare Products value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 27: North America Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 28: North America Other OTC Healthcare Products company share (Top 5 companies), by value, 2005-2006 (%); Figure 29: North America Topical OTC medicines value & value forecast, 2001-2011 (US$ m, nominal prices); Figure 30: North America Topical OTC medicines category growth comparison, by value, 2001-2011; Figure 31: North America Topical OTC medicines company share by value, 2005-2006 (%); Figure 32: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: North America OTC Healthcare value (country-wise), 2001-2006 (US$ m, nominal prices); Table 3: North America OTC Healthcare value (country-wise) forecast, 2006-2011 (US$ m, nominal prices); Table 4: North America OTC Healthcare value, 2001-2006 (US$ m, nominal prices); Table 5: North America OTC Healthcare value forecast, 2006-2011 (US$ m, nominal prices); Table 6: North America OTC Healthcare company share (Top 20 Companies) by value, 2005-2006 (%); Table 7: North America OTC Healthcare value, by company, 2005-2006 (US$ m nominal prices); Table 8: Pfizer Inc Key Facts; Table 9: GlaxoSmithKline Key Facts; Table 10: North America Analgesics value, 2001-2006 (US$ m, nominal prices); Table 11: North America Analgesics value forecast, 2006-2011 (US$ m, nominal prices); Table 12: North America Analgesics company share by value, 2005-2006 (%); Table 13: North America Analgesics value, by company, 2005-2006 (US$ m nominal prices); Table 14: North America Cough and Cold Preparations value, 2001-2006 (US$ m, nominal prices); Table 15: North America Cough and Cold Preparations value forecast, 2006-2011 (US$ m, nominal prices); Table 16: North America Cough and Cold Preparations company share by value, 2005-2006 (%); Table 17: North America Cough and Cold Preparations value, by company, 2005-2006 (US$ m nominal prices); Table 18: North America Traditional Medicines value, 2001-2006 (US$ m, nominal prices); Table 19: North America Traditional Medicines value forecast, 2006-2011 (US$ m, nominal prices); Table 20: North America Traditional Medicines company share by value, 2005-2006 (%); Table 21: North America Traditional Medicines value, by company, 2005-2006 (US$ m nominal prices); Table 22: North America First Aid Kits value, 2001-2006 (US$ m, nominal prices); Table 23: North America First Aid Kits value forecast, 2006-2011 (US$ m, nominal prices); Table 24: North America First Aid Kits company share by value, 2005-2006 (%); Table 25: North America First Aid Kits value, by company, 2005-2006 (US$ m nominal prices); Table 26: North America Indigestion Preparations value, 2001-2006 (US$ m, nominal prices); Table 27: North America Indigestion Preparations value forecast, 2006-2011 (US$ m, nominal prices); Table 28: North America Indigestion Preparations company share by value, 2005-2006 (%); Table 29: North America Indigestion Preparations value, by company, 2005-2006 (US$ m nominal prices); Table 30: North America Vitamins and Minerals value, 2001-2006 (US$ m, nominal prices); Table 31: North America Vitamins and Minerals value forecast, 2006-2011 (US$ m, nominal prices); Table 32: North America Vitamins and Minerals company share by value, 2005-2006 (%); Table 33: North America Vitamins and Minerals value, by company, 2005-2006 (US$ m nominal prices); Table 34: North America Plasters & Bandages value, 2001-2006 (US$ m, nominal prices); Table 35: North America Plasters & Bandages value forecast, 2006-2011 (US$ m, nominal prices); Table 36: North America Plasters & Bandages company share by value, 2005-2006 (%); Table 37: North America Plasters & Bandages value, by company, 2005-2006 (US$ m nominal prices); Table 38: North America Medicated Skin Products value, 2001-2006 (US$ m, nominal prices); Table 39: North America Medicated Skin Products value forecast, 2006-2011 (US$ m, nominal prices); Table 40: North America Medicated Skin Products company share by value, 2005-2006 (%); Table 41: North America Medicated Skin Products value, by company, 2005-2006 (US$ m nominal prices); Table 42: North America Other OTC Healthcare Products value, 2001-2006 (US$ m, nominal prices); Table 43: North America Other OTC Healthcare Products value forecast, 2006-2011 (US$ m, nominal prices); Table 44: North America Other OTC Healthcare Products company share (Top 20 Companies) by value, 2005-2006 (%); Table 45: North America Other OTC Healthcare Products value, by company, 2005-2006 (US$ m nominal prices); Table 46: North America Topical OTC Medicines value, 2001-2006 (US$ m, nominal prices); Table 47: North America Topical OTC Medicines value forecast, 2006-2011 (US$ m, nominal prices); Table 48: North America Topical OTC Medicines company share by value, 2005-2006 (%); Table 49: North America Topical OTC Medicines value, by company, 2005-2006 (US$ m nominal prices)

More North America Over-the-Counter Drugs Reports

Medicated Skin Care in Mexico by Euromonitor International
Diabetes rates are soaring in Mexico due to unhealthy diets and obesity, reaching more than nine million people in 2011 according to the Mexican Diabetes ...

Herbal/Traditional Products in Mexico by Euromonitor International
Herbal/traditional remedies in Mexico have a very long tradition dating back over 1,000 years. A large proportion of herbal remedies consumed in Mexico are produced ...

Ear Care in Mexico by Euromonitor International
In December 2010 Novartis bought the rest of Alcon, Inc. for US$12.9 billion – the largest deal in Swiss corporate history. Alcon’s Orla-Wax is the ...

Digestive Remedies in Mexico by Euromonitor International
Self-prescription is a widely extended practice in overall Mexican consumer health. There is practically no format (parapharmacies, chemists/pharmacies, large retailers, variety stores) that constitutes an ...

Cough, Cold and Allergy (Hay Fever) Remedies in Mexico by Euromonitor International
In response to issues with excessive self-medication that arose during the H1N1 outbreak, the Mexican authorities passed a law in 2010 banning sales of antibiotics ...

See all reports like this >>

More North America Reports

Spirits – Mexico – a snapshot (2011) by Mintel - Snapshots
Spirits in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers all ...

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Mexico by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Canada by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

See all reports like this >>

OTC Healthcare in North America to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service